Financial performance 2019/20.

Germany is again the strongest performing region in the EOS Group. The decline in respect of the previous reporting period resulted primarily from the sale of EOS Health Honorarmanagement AG. On the fiercely competitive German market, EOS was able to win some significant receivables packages and increase the investment volume compared with the previous year. By systematically pursuing its strategy of risk diversification in existing markets, EOS was able to again increase its share of revenue, especially in Eastern and Western Europe. EOS companies in Eastern Europe achieved a particularly high increase in revenue of 31.3 percent. This can largely be attributed to much higher revenues from receivables purchases, especially in Russia and Poland, but also in Croatia and Hungary. Western Europe also had a very gratifying operating performance, particularly in Belgium, France and Austria. This region closed the financial year with a year-on-year increase in revenue of five percent. EOS subsidiaries in North America also reported a five percent increase.

2019/20 was also successful in respect of the bottom line: EOS Consolidated reported a net income of EUR 269.9 million, an increase of 15.2 percent.

Despite the sale of two group companies in the 2018/19 reference year, sales revenues in the reporting year were up by 4.8 percent, or EUR 39.4 million. The EBITDA saw an even greater increase than the sales revenues. However, compared with the previous reporting period this was aided by the first-time application of the IFRS 16 standard (reallocation of lease expenses). The EBT (+13 percent), which is comparable to the previous year, and the net income (+15.2 percent) has increased significantly more than the revenue. In both periods the result is underpinned by non-recurring earnings from the sale of subsidiaries, which are shown in the financial result.

The total assets of EOS Consolidated decreased by 0.5 percent year-on-year to EUR 2.2 billion. As well as being a consequence of increased working capital management, this decline was due primarily to the sale of EOS Health Honorarmanagement AG. This was counteracted by the ongoing intensive investment in secured and unsecured portfolios, whose book value increased in the last fiscal year by around EUR 200 million to EUR 1.83 billion. Purchased portfolios and real estate in inventories accounted for 83.3 percent of total assets. Other contributing factors were the systematic high level of investment in cutting-edge debt collection systems and the use of advanced analytics, as well as usage rights activated for the first time in accordance with IFRS 16.

^{*Includes portfolio investments reported as loans receivable for structural reasons (financial presentation).}

In the last financial year, the sale of EOS Health Honorarmanagement AG also influenced the total financing of EOS Consolidated. However, EOS was able to increase its equity through profit retention from the previous year and the issue of new profit-sharing rights. The equity-to-assets ratio rose by almost five percent to 33.5 percent, a comparatively high level for a financial services provider: The high positive free cash flow could be used to reduce the volume of refinancing from banks and the parent company, so that their share of debt financing was reduced by 5.9 percent compared with the previous year.